Group One Trading’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-840,500
| Closed | -$71.5M | – | 7323 |
|
|
2020
Q3 | $71.5M | Buy |
840,500
+469,000
| +126% | +$23.7M | 0.22% | 63 |
|
|
2020
Q2 | $13.2M | Buy |
371,500
+282,800
| +319% | +$8.27M | 0.06% | 351 |
|
|
2020
Q1 | $1.2M | Sell |
88,700
-374,500
| -81% | -$6.3M | 0.01% | 1391 |
|
|
2019
Q4 | $9.8M | Buy |
463,200
+48,700
| +12% | +$859K | 0.07% | 352 |
|
|
2019
Q3 | $5.5M | Buy |
414,500
+27,600
| +7% | +$406K | 0.04% | 525 |
|
|
2019
Q2 | $5.37M | Buy |
386,900
+126,400
| +49% | +$1.9M | 0.05% | 481 |
|
|
2019
Q1 | $5M | Sell |
260,500
-543,100
| -68% | -$8.75M | 0.06% | 423 |
|
|
2018
Q4 | $11.5M | Buy |
803,600
+347,100
| +76% | +$6.89M | 0.1% | 209 |
|
|
2018
Q3 | $9.51M | Sell |
456,500
-166,900
| -27% | -$3.95M | 0.08% | 301 |
|
|
2018
Q2 | $14.8M | Sell |
623,400
-94,400
| -13% | -$1.9M | 0.13% | 158 |
|
|
2018
Q1 | $10.5M | Sell |
717,800
-822,900
| -53% | -$13.4M | 0.11% | 214 |
|
|
2017
Q4 | $24.9M | Buy |
1,540,700
+294,900
| +24% | +$3.48M | 0.18% | 102 |
|
|
2017
Q3 | $17.4M | Sell |
1,245,800
-34,000
| -3% | -$339K | 0.16% | 122 |
|
|
2017
Q2 | $11.3M | Buy |
1,279,800
+306,300
| +31% | +$2.15M | 0.12% | 189 |
|
|
2017
Q1 | $6.3M | Buy |
973,500
+226,100
| +30% | +$1.15M | 0.07% | 330 |
|
|
2016
Q4 | $2.74M | Buy |
747,400
+604,800
| +424% | +$1.79M | 0.03% | 746 |
|
|
2016
Q3 | $463K | Sell |
142,600
-190,100
| -57% | -$532K | 0.01% | 1876 |
|
|
2016
Q2 | $772K | Buy |
332,700
+22,400
| +7% | +$74.9K | 0.01% | 1417 |
|
|
2016
Q1 | $776K | Buy |
310,300
+145,200
| +88% | +$327K | 0.01% | 1363 |
|
|
2015
Q4 | $507K | Sell |
165,100
-192,600
| -54% | -$538K | 0.01% | 1812 |
|
|
2015
Q3 | $615K | Sell |
357,700
-127,900
| -26% | -$326K | 0.01% | 1613 |
|
|
2015
Q2 | $1.97M | Buy |
485,600
+311,700
| +179% | +$1.27M | 0.03% | 758 |
|
|
2015
Q1 | $666K | Sell |
173,900
-127,200
| -42% | -$553K | 0.01% | 1387 |
|
|
2014
Q4 | $1.45M | Buy |
301,100
+73,500
| +32% | +$291K | 0.02% | 833 |
|
|
2014
Q3 | $847K | Sell |
227,600
-36,000
| -14% | -$122K | 0.01% | 1222 |
|
|
2014
Q2 | $962K | Sell |
263,600
-62,500
| -19% | -$229K | 0.01% | 1165 |
|
|
2014
Q1 | $1.37M | Sell |
326,100
-856,200
| -72% | -$4.25M | 0.02% | 861 |
|
|
2013
Q4 | $5.44M | Buy |
1,182,300
+520,700
| +79% | +$2.32M | 0.08% | 236 |
|
|
2013
Q3 | $4.09M | Sell |
661,600
-67,800
| -9% | -$390K | 0.08% | 269 |
|
|
2013
Q2 | $3.97M | Buy |
+729,400
| New | +$2.4M | 0.1% | 197 |
|
Group One Trading's IMMU Position: Q4 2020 in Review
Group One Trading sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 50,018 shares — an estimated $4.25M sold.
Group One Trading first reported a position in IMMU in Q2 2013 and held it in 22 quarters. The position peaked at $6.51M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Group One Trading reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Group One Trading sold 50,018 Immunomedics Inc shares in Q4 2020, an estimated $4.25M.
- Group One Trading first reported a position in Immunomedics Inc in Q2 2013 and held it in 22 quarters.
- Group One Trading's Immunomedics Inc position peaked at $6.51M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.